These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 22186792)
1. Self-complementary AAVs induce more potent transgene product-specific immune responses compared to a single-stranded genome. Wu T; Töpfer K; Lin SW; Li H; Bian A; Zhou XY; High KA; Ertl HC Mol Ther; 2012 Mar; 20(3):572-9. PubMed ID: 22186792 [TBL] [Abstract][Full Text] [Related]
2. Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice. Lin SW; Hensley SE; Tatsis N; Lasaro MO; Ertl HC J Clin Invest; 2007 Dec; 117(12):3958-70. PubMed ID: 18008010 [TBL] [Abstract][Full Text] [Related]
3. The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver. Martino AT; Suzuki M; Markusic DM; Zolotukhin I; Ryals RC; Moghimi B; Ertl HC; Muruve DA; Lee B; Herzog RW Blood; 2011 Jun; 117(24):6459-68. PubMed ID: 21474674 [TBL] [Abstract][Full Text] [Related]
4. Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B. Rogers GL; Martino AT; Zolotukhin I; Ertl HC; Herzog RW J Transl Med; 2014 Jan; 12():25. PubMed ID: 24460861 [TBL] [Abstract][Full Text] [Related]
5. The effect of adenovirus-specific antibodies on adenoviral vector-induced, transgene product-specific T cell responses. Small JC; Haut LH; Bian A; Ertl HC J Leukoc Biol; 2014 Nov; 96(5):821-31. PubMed ID: 25082150 [TBL] [Abstract][Full Text] [Related]
6. The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. Zhu J; Huang X; Yang Y J Clin Invest; 2009 Aug; 119(8):2388-98. PubMed ID: 19587448 [TBL] [Abstract][Full Text] [Related]
7. Enhancing transduction of the liver by adeno-associated viral vectors. Nathwani AC; Cochrane M; McIntosh J; Ng CY; Zhou J; Gray JT; Davidoff AM Gene Ther; 2009 Jan; 16(1):60-9. PubMed ID: 18701909 [TBL] [Abstract][Full Text] [Related]
8. The Effect of CpG Sequences on Capsid-Specific CD8 Xiang Z; Kurupati RK; Li Y; Kuranda K; Zhou X; Mingozzi F; High KA; Ertl HCJ Mol Ther; 2020 Mar; 28(3):771-783. PubMed ID: 31839483 [TBL] [Abstract][Full Text] [Related]
9. T Cell-Mediated Immune Responses to AAV and AAV Vectors. Ertl HCJ Front Immunol; 2021; 12():666666. PubMed ID: 33927727 [TBL] [Abstract][Full Text] [Related]
10. Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteins. Mays LE; Vandenberghe LH; Xiao R; Bell P; Nam HJ; Agbandje-McKenna M; Wilson JM J Immunol; 2009 May; 182(10):6051-60. PubMed ID: 19414756 [TBL] [Abstract][Full Text] [Related]
11. Genomic stability of self-complementary adeno-associated virus 2 during early stages of transduction in mouse muscle in vivo. Ren C; Kumar S; Shaw DR; Ponnazhagan S Hum Gene Ther; 2005 Sep; 16(9):1047-57. PubMed ID: 16149903 [TBL] [Abstract][Full Text] [Related]
12. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors. Manning WC; Zhou S; Bland MP; Escobedo JA; Dwarki V Hum Gene Ther; 1998 Mar; 9(4):477-85. PubMed ID: 9525309 [TBL] [Abstract][Full Text] [Related]
13. Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid. Timmers AM; Newmark JA; Turunen HT; Farivar T; Liu J; Song C; Ye GJ; Pennock S; Gaskin C; Knop DR; Shearman MS Hum Gene Ther; 2020 Jan; 31(1-2):80-89. PubMed ID: 31544533 [TBL] [Abstract][Full Text] [Related]
14. Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity. Zhang YC; Powers M; Wasserfall C; Brusko T; Song S; Flotte T; Snyder RO; Potter M; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Nick HS; Agarwal A; Ellis TM; Atkinson MA Gene Ther; 2004 Feb; 11(3):233-40. PubMed ID: 14737082 [TBL] [Abstract][Full Text] [Related]
15. Pre-Existing Immunity to a Nucleic Acid Contaminant-Derived Antigen Mediates Transaminitis and Resultant Diminished Transgene Expression in a Mouse Model of Hepatic Recombinant Adeno-Associated Virus-Mediated Gene Transfer. Brimble MA; Morton CL; Winston SM; Reeves IL; Spence Y; Cheng PH; Zhou J; Nathwani AC; Thomas PG; Souquette A; Davidoff AM Hum Gene Ther; 2024 Jul; 35(13-14):477-489. PubMed ID: 38420654 [TBL] [Abstract][Full Text] [Related]
16. Early interaction of adeno-associated virus serotype 8 vector with the host immune system following intramuscular delivery results in weak but detectable lymphocyte and dendritic cell transduction. Gernoux G; Guilbaud M; Dubreil L; Larcher T; Babarit C; Ledevin M; Jaulin N; Planel P; Moullier P; Adjali O Hum Gene Ther; 2015 Jan; 26(1):1-13. PubMed ID: 25333770 [TBL] [Abstract][Full Text] [Related]
17. Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies. Garber DA; O'Mara LA; Zhao J; Gangadhara S; An I; Feinberg MB PLoS One; 2009; 4(5):e5445. PubMed ID: 19421328 [TBL] [Abstract][Full Text] [Related]
18. AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells. Mingozzi F; Meulenberg JJ; Hui DJ; Basner-Tschakarjan E; Hasbrouck NC; Edmonson SA; Hutnick NA; Betts MR; Kastelein JJ; Stroes ES; High KA Blood; 2009 Sep; 114(10):2077-86. PubMed ID: 19506302 [TBL] [Abstract][Full Text] [Related]
19. The Balance between CD8 Kumar SRP; Hoffman BE; Terhorst C; de Jong YP; Herzog RW Mol Ther; 2017 Apr; 25(4):880-891. PubMed ID: 28284982 [TBL] [Abstract][Full Text] [Related]
20. Vaccines based on novel adeno-associated virus vectors elicit aberrant CD8+ T-cell responses in mice. Lin J; Zhi Y; Mays L; Wilson JM J Virol; 2007 Nov; 81(21):11840-9. PubMed ID: 17715240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]